Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
$16.47
$16.09
$5.94
$17.55
$3.37B1.993.22 million shs523,503 shs
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
$2.05
$2.05
$1.85
$5.09
$33.61M0.1111,322 shsN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.26
+0.3%
$29.00
$23.69
$31.72
$13.21B0.69815,726 shs274,870 shs
Solventum Corporation stock logo
SOLV
Solventum
$77.90
-0.4%
$72.43
$47.16
$85.92
$13.54B0.551.12 million shs474,266 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
0.00%0.00%0.00%0.00%0.00%
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
0.00%0.00%0.00%0.00%-59.72%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
+0.33%+0.21%+3.86%+14.92%+20.41%
Solventum Corporation stock logo
SOLV
Solventum
-0.40%+4.26%+4.94%+17.65%+53.20%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
N/AN/AN/AN/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3.6987 of 5 stars
1.05.02.50.03.00.04.4
Solventum Corporation stock logo
SOLV
Solventum
0.9595 of 5 stars
1.15.00.00.03.40.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
0.00
N/AN/AN/A
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
0.00
N/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$28.00-7.47% Downside
Solventum Corporation stock logo
SOLV
Solventum
2.18
Hold$81.504.62% Upside

Current Analyst Ratings Breakdown

Latest ONEM, SHLT, SOLV, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/1/2025
Solventum Corporation stock logo
SOLV
Solventum
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$90.00
6/6/2025
Solventum Corporation stock logo
SOLV
Solventum
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
5/19/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$78.00 ➝ $87.00
5/9/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$80.00 ➝ $78.00
5/1/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$27.00 ➝ $28.00
4/30/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$84.00 ➝ $80.00
4/25/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/25/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
$1.05B3.22N/AN/A$9.06 per share1.82
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
$55.94M0.60$0.04 per share54.03$5.21 per share0.39
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.28$3.17 per share9.55$12.04 per share2.51
Solventum Corporation stock logo
SOLV
Solventum
$8.25B1.63$9.90 per share7.87$17.13 per share4.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
-$254.64M-$2.01N/AN/AN/A-38.05%-24.58%-15.62%N/A
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
-$7.06MN/A0.00N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1614.0115.130.93N/AN/AN/A8/5/2025 (Estimated)
Solventum Corporation stock logo
SOLV
Solventum
$478M$2.1636.0614.192.004.55%31.01%6.53%8/4/2025 (Estimated)

Latest ONEM, SHLT, SOLV, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Solventum Corporation stock logo
SOLV
Solventum
$1.19$1.34+$0.15$0.78$2.02 billion$2.07 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
N/AN/AN/AN/AN/A
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.94%N/A41.20%N/A
Solventum Corporation stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
0.20
2.09
2.06
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
0.19
2.17
1.98
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.89
1.33
Solventum Corporation stock logo
SOLV
Solventum
2.40
1.19
0.85

Institutional Ownership

CompanyInstitutional Ownership
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
78.20%
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
20.11%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%
Solventum Corporation stock logo
SOLV
Solventum
N/A

Insider Ownership

CompanyInsider Ownership
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
4.40%
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
Solventum Corporation stock logo
SOLV
Solventum
0.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
3,090204.35 million195.36 millionOptionable
SHL Telemedicine Ltd. stock logo
SHLT
SHL Telemedicine
58316.39 millionN/ANot Optionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.97 million433.59 millionOptionable
Solventum Corporation stock logo
SOLV
Solventum
22,000173.01 million172.93 millionOptionable

Recent News About These Companies

Argus Upgrades Solventum (NYSE:SOLV) to Buy
Argus Research Upgrades Solventum (SOLV)
Solventum (NYSE:SOLV) Raised to "Buy" at Argus

New MarketBeat Followers Over Time

Media Sentiment Over Time

1Life Healthcare stock logo

1Life Healthcare NASDAQ:ONEM

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.

SHL Telemedicine stock logo

SHL Telemedicine NASDAQ:SHLT

$2.05 0.00 (0.00%)
As of 04/16/2025

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use. It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$30.26 +0.10 (+0.33%)
As of 07/3/2025 03:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum stock logo

Solventum NYSE:SOLV

$77.90 -0.35 (-0.45%)
Closing price 07/3/2025 03:40 PM Eastern
Extended Trading
$77.90 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.